Arnold Ganser
Impact in
- Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.02%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 678
- Acute Myeloid Leukemia Research 492
- Hematopoietic Stem Cell Transplantation 224
- Chronic Myeloid Leukemia Treatments 126
- Genetics 186
- Myeloproliferative Neoplasms: Diagnosis and Treatment 85
- Chronic Lymphocytic Leukemia Research 59
- Co-authors
- Bernd Hertenstein (54 shared papers)Felicitas R. Thol (78 shared papers)Michael Heuser (105 shared papers)Jürgen Krauter (80 shared papers)Gerhard Heil (69 shared papers)Brigitte Schlegelberger (66 shared papers)Hartmut Doehner (73 shared papers)Matthias Eder (79 shared papers)
- Journals
- Blood (236 papers)Annals of Hematology (77 papers)Leukemia (61 papers)Bone Marrow Transplantation (35 papers)British Journal of Haematology (33 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Arnold Ganser
957 papers receiving 48.4k citations
Arnold Ganser's Hit Papers
Peers
Comparison fields: 5 of 182
- Hematology 29.3k
- Genetics 10.6k
- Cancer Research 4.3k
- Oncology 6.5k
- Public Health, Environmental and Occupational Health 6.9k
Countries citing papers authored by Arnold Ganser
This map shows the geographic impact of Arnold Ganser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnold Ganser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnold Ganser more than expected).
Fields of papers citing papers by Arnold Ganser
This network shows the impact of papers produced by Arnold Ganser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnold Ganser. The network helps show where Arnold Ganser may publish in the future.
Co-authors
The 25 scholars most cited alongside Arnold Ganser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 992 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Genomic Classification and Prognosis in Acute Myeloid Leukemia Hit paper breakdown → | 2016 | 3337 |
| 2 | Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation Hit paper breakdown → | 2017 | 1785 |
| 3 | Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial Hit paper breakdown → | 2004 | 1769 |
| 4 | Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia Hit paper breakdown → | 2008 | 1364 |
| 5 | Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia Hit paper breakdown → | 2013 | 1262 |
| 6 | Intracoronary Bone Marrow Cell Transfer After Myocardial Infarction Hit paper breakdown → | 2006 | 795 |
| 7 | Monitoring of Bone Marrow Cell Homing Into the Infarcted Human Myocardium Hit paper breakdown → | 2005 | 784 |
| 8 | Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma Hit paper breakdown → | 2010 | 707 |
| 9 | TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome Hit paper breakdown → | 2011 | 564 |
| 10 | Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults Hit paper breakdown → | 1988 | 491 |
| 11 | Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group Hit paper breakdown → | 2011 | 474 |
| 12 | 2010 | 445 | |
| 13 | 2009 | 419 | |
| 14 | Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies Hit paper breakdown → | 2012 | 416 |
| 15 | 2011 | 410 | |
| 16 | 2011 | 397 | |
| 17 | 2010 | 395 | |
| 18 | 2012 | 371 | |
| 19 | 2006 | 365 | |
| 20 | 2011 | 352 |
About Arnold Ganser
Arnold Ganser is a scholar working on Hematology, Genetics, Oncology, Public Health, Environmental and Occupational Health and Immunology, having authored 992 papers that have together received 49.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (492 papers), Hematopoietic Stem Cell Transplantation (224 papers), Acute Lymphoblastic Leukemia research (152 papers), Chronic Myeloid Leukemia Treatments (126 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (85 papers), Retinoids in leukemia and cellular processes (66 papers), Neutropenia and Cancer Infections (62 papers) and Chronic Lymphocytic Leukemia Research (59 papers). The work is most often cited by research in Hematology (29.3k citations), Genetics (10.6k citations), Cancer Research (4.3k citations), Oncology (6.5k citations) and Public Health, Environmental and Occupational Health (6.9k citations). Arnold Ganser has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Bernd Hertenstein, Felicitas R. Thol, Michael Heuser, Jürgen Krauter, Gerhard Heil, Brigitte Schlegelberger, Hartmut Doehner, Matthias Eder, Kai Christoph Wollert and Richard F Schlenk. Their work appears in journals such as Blood, Annals of Hematology, Leukemia, Bone Marrow Transplantation and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.